Literature DB >> 21342073

Adenosine modulates Toll-like receptor function: basic mechanisms and translational opportunities.

Melanie R Power Coombs1, Mirjam E Belderbos, Leighanne C Gallington, Louis Bont, Ofer Levy.   

Abstract

Adenosine is an endogenous purine metabolite whose concentration in human blood plasma rises from nanomolar to micromolar concentrations during the inflammatory process. Leukocytes express seven-transmembrane adenosine receptors whose engagement modulates Toll-like receptor-mediated cytokine responses, in part via modulation of intracellular cyclic adenosine monophosphate. Adenosine analogs are used clinically to treat arrhythmias and apnea of prematurity. Herein, we consider the potential of adenosine analogs as innate immune response modifiers to prevent and/or treat infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21342073      PMCID: PMC4052217          DOI: 10.1586/eri.10.158

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  87 in total

Review 1.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

Review 2.  Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation.

Authors:  M J L Bours; E L R Swennen; F Di Virgilio; B N Cronstein; P C Dagnelie
Journal:  Pharmacol Ther       Date:  2006-06-19       Impact factor: 12.310

Review 3.  Spatiotemporal control of cAMP signalling processes by anchored signalling complexes.

Authors:  E Jarnaess; K Taskén
Journal:  Biochem Soc Trans       Date:  2007-11       Impact factor: 5.407

4.  NTPDase1 governs P2X7-dependent functions in murine macrophages.

Authors:  Sébastien A Lévesque; Filip Kukulski; Keiichi Enjyoji; Simon C Robson; Jean Sévigny
Journal:  Eur J Immunol       Date:  2010-05       Impact factor: 5.532

5.  Inhibiting adenosine deaminase modulates the systemic inflammatory response syndrome in endotoxemia and sepsis.

Authors:  Simon Adanin; Igor V Yalovetskiy; Beth A Nardulli; Albert D Sam; Zivojin S Jonjev; William R Law
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2002-05       Impact factor: 3.619

6.  CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness.

Authors:  Norikatsu Mizumoto; Tadashi Kumamoto; Simon C Robson; Jean Sévigny; Hiroyuki Matsue; Keiichi Enjyoji; Akira Takashima
Journal:  Nat Med       Date:  2002-04       Impact factor: 53.440

7.  Gene dosage determines the negative effects of polymorphic alleles of the P2X7 receptor on adenosine triphosphate-mediated killing of mycobacteria by human macrophages.

Authors:  Suran L Fernando; Bernadette M Saunders; Ronald Sluyter; Kristen K Skarratt; James S Wiley; Warwick J Britton
Journal:  J Infect Dis       Date:  2005-05-31       Impact factor: 5.226

8.  Caffeine for Apnea of Prematurity trial: benefits may vary in subgroups.

Authors:  Peter G Davis; Barbara Schmidt; Robin S Roberts; Lex W Doyle; Elizabeth Asztalos; Ross Haslam; Sunil Sinha; Win Tin
Journal:  J Pediatr       Date:  2009-11-18       Impact factor: 4.406

9.  An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors.

Authors:  Grace Pinhal-Enfield; Madhuri Ramanathan; Gyorgy Hasko; Stefanie N Vogel; Andrew L Salzman; Geert-Jan Boons; S Joseph Leibovich
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

10.  cAMP elevators inhibit LPS-induced IL-12 p40 expression by interfering with phosphorylation of p38 MAPK in murine peritoneal macrophages.

Authors:  Wei Guo Feng; Yi Bing Wang; Jin Song Zhang; Xing Yu Wang; Chang Lin Li; Zong Liang Chang
Journal:  Cell Res       Date:  2002-12       Impact factor: 25.617

View more
  20 in total

Review 1.  Toll-like receptor signaling in primary immune deficiencies.

Authors:  Paul J Maglione; Noa Simchoni; Charlotte Cunningham-Rundles
Journal:  Ann N Y Acad Sci       Date:  2015-04-30       Impact factor: 5.691

Review 2.  Role of innate immunity in neonatal infection.

Authors:  Alex G Cuenca; James L Wynn; Lyle L Moldawer; Ofer Levy
Journal:  Am J Perinatol       Date:  2013-01-07       Impact factor: 1.862

3.  High expression levels of macrophage migration inhibitory factor sustain the innate immune responses of neonates.

Authors:  Thierry Roger; Anina Schneider; Manuela Weier; Fred C G J Sweep; Didier Le Roy; Jürgen Bernhagen; Thierry Calandra; Eric Giannoni
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-08       Impact factor: 11.205

4.  Imidazoquinoline Toll-like receptor 8 agonists activate human newborn monocytes and dendritic cells through adenosine-refractory and caspase-1-dependent pathways.

Authors:  Victoria J Philbin; David J Dowling; Leighanne C Gallington; Guadalupe Cortés; Zhen Tan; Eugénie E Suter; Kevin W Chi; Ariel Shuckett; Liat Stoler-Barak; Mark Tomai; Richard L Miller; Keith Mansfield; Ofer Levy
Journal:  J Allergy Clin Immunol       Date:  2012-04-21       Impact factor: 10.793

Review 5.  Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly.

Authors:  Tobias R Kollmann; Ofer Levy; Ruth R Montgomery; Stanislas Goriely
Journal:  Immunity       Date:  2012-11-16       Impact factor: 31.745

6.  Macrophage A2A adenosinergic receptor modulates oxygen-induced augmentation of murine lung injury.

Authors:  Neil R Aggarwal; Franco R D'Alessio; Yoshiki Eto; Eric Chau; Claudia Avalos; Adam T Waickman; Brian T Garibaldi; Jason R Mock; Daniel C Files; Venkataramana Sidhaye; Vsevolod Y Polotsky; Jonathan Powell; Maureen Horton; Landon S King
Journal:  Am J Respir Cell Mol Biol       Date:  2013-05       Impact factor: 6.914

7.  Defective B cell tolerance in adenosine deaminase deficiency is corrected by gene therapy.

Authors:  Aisha V Sauer; Henner Morbach; Immacolata Brigida; Yen-Shing Ng; Alessandro Aiuti; Eric Meffre
Journal:  J Clin Invest       Date:  2012-05-24       Impact factor: 14.808

Review 8.  Nanoceutical Adjuvants as Wound Healing Material: Precepts and Prospects.

Authors:  Kaushita Banerjee; Radha Madhyastha; Yuichi Nakajima; Masugi Maruyama; Harishkumar Madhyastha
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

9.  Autoimmune dysregulation and purine metabolism in adenosine deaminase deficiency.

Authors:  Aisha Vanessa Sauer; Immacolata Brigida; Nicola Carriglio; Alessandro Aiuti
Journal:  Front Immunol       Date:  2012-08-27       Impact factor: 7.561

10.  The ultra-potent and selective TLR8 agonist VTX-294 activates human newborn and adult leukocytes.

Authors:  David J Dowling; Zhen Tan; Zofia M Prokopowicz; Christine D Palmer; Maura-Ann H Matthews; Gregory N Dietsch; Robert M Hershberg; Ofer Levy
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.